Xeris Pharmaceuticals Inc | XERS - Current Assets

Xeris Pharmaceuticals Inc reported $186.82M in Current Assets for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Current Assets Change
Acelrx Pharmaceuticals ACRX:US USD 24.54M 7.46M
Endo International Ordinary Shares ENDP:US USD 2.05B 145.74M
Horizon Pharma HZNP:US USD 3.65B 240.83M
JAZZ PHA JAZZ:US USD 2.61B 34.64M
Nektar Therapeutics NKTR:US USD 545.97M 53.52M
Pacira Pharmaceuticals PCRX:US USD 498.33M 35.08M
Perrigo Ordinary Shares PRGO:US USD 2.72B 136.6M
Supernus Pharmaceuticals SUPN:US USD 734.15M 70.26M
Teva Pharmaceutical Industries TEVA:US USD 12.05B 598M